| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |